OHSU Knight Cancer Institute in Portland, directed by Dr. Brian Druker (pioneer of Gleevec / imatinib), is internationally famed for pioneering targeted cancer therapy and early tumor detection technologies. Learn about top NCI institutions, leading hospital networks, clinical trials, and patient navigation in Oregon.
Portland, Oregon
Over 400 active clinical trials with world leadership in targeted genomics and immunotherapies.
The OHSU Knight Cancer Institute in Portland is Oregon's only NCI-Designated Comprehensive Cancer Center, globally famous for developing targeted therapies for leukemia and GIST.
ByOnco matches patients to OHSU Knight specialists, helps coordinate precision genomic profiling interpretations, and provides 24/7 clinical AI support between appointments.
Connect with our clinical navigation team to verify center in-network status, organize second opinions, and review clinical trials.
Essential cookies run the site. Optional analytics help us improve. Manage choices anytime in Cookie Settings. See our Privacy Policy and Cookie Policy.